RIVANNA's Accuro 3S Needle Guide Kit Receives FDA Clearance for Enhanced Patient Safety RIVANNA announces FDA approval for Accuro 3S Needle Guide Kit, advancing ultrasound-guided needle placement safety and efficiency.

RIVANNA's Accuro 3S Needle Guide Kit Receives FDA Clearance for Enhanced Patient Safety #United_States #FDA_Clearance #Charlottesville #RIVANNA #Accuro_3S

RIVANNA Clinches Finalist Spot in Prestigious MedTech Innovator Competition RIVANNA, a pioneer in imaging-based medical technologies, has emerged as a finalist in the 2025 MedTech Innovator competition, vying for significant funding and recognition.

RIVANNA Clinches Finalist Spot in Prestigious MedTech Innovator Competition #United_States #Charlottesville #RIVANNA #MedTech_Innovator #Accuro_3S

RIVANNA Receives $800,000 Grant to Enhance AI Ultrasound for Neuraxial Anesthesia RIVANNA has secured $800,000 from the Virginia Catalyst Grant to advance their innovative AI-driven ultrasound system, enhancing neuraxial anesthesia procedures.

RIVANNA Receives $800,000 Grant to Enhance AI Ultrasound for Neuraxial Anesthesia #United_States #Charlottesville #RIVANNA #Accuro_3S #Virginia_Catalyst

RIVANNA Achieves FDA Clearance for Ultrasound Guidance and AI Imaging Solutions RIVANNA has received FDA 510(k) clearance for its Accuro 3S ultrasound system and SpineNav-AI software, enhancing precision in spinal procedures.

RIVANNA Achieves FDA Clearance for Ultrasound Guidance and AI Imaging Solutions #United_States #Charlottesville #RIVANNA #Accuro_3S #SpineNav-AI

RIVANNA Chosen for MedTech Innovator 2025 Accelerator Program RIVANNA has been selected for the prestigious MedTech Innovator 2025 Accelerator program, marking a significant milestone in healthcare innovation.

RIVANNA Chosen for MedTech Innovator 2025 Accelerator Program #United_States #MedTech #Charlottesville #RIVANNA #Accuro_3S